|Day Low/High||32.70 / 33.25|
|52 Wk Low/High||31.90 / 58.16|
A firestorm in Washington has created a fire sale for shares of this undervalued stock.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) will host a live audio webcast at the Cowen & Company 37 th Annual Healthcare Conference in Boston, MA.
The scandals plaguing the pharmaceutical company can be traced to lack of change at the board level.
Forty states have now sued the companies.
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of generic Pristiq ®1 (desvenlafaxine) extended-release tablets, 25, 50 and 100 mg, in the U.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) today announced the U.
These two large-cap drug giants should be core parts of any well-diversified portfolio.
In accordance with Section 203.01 of the New York Stock Exchange Listed Company Manual, Teva Pharmaceutical Industries Ltd.
Allergan's most-recent quarterly financial report for Q4/2016 showed solid results.
Wall Street rallies to new records as leftover goodwill from Friday's rally pushes stocks to new heights.
The good vibes that carried Wall Street to new records last week lingered on into Monday's session.
The Dow Jones Industrial Average led Wall Street's gains on Monday on leftover goodwill from last week's Trump-inspired rally.
Here's how to trade seven of the most active names on the market.
Allergan is buying body-sculptor Zeltiq. CEO Brent Saunders deems it to be the Botox of 10 years ago and he expects the deal to be immediately accretive.
Stocks edge higher on Monday as good vibes from Friday's record-breaking rally are sustained through the weekend.
The company had been free falling after CEO Erez Vigodman stepped down last week.
That support could become necessary should the blooming flower of tax reform come with a couple of thorns attached.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) today reported results for the year and the quarter ended December 31, 2016.
Cramer shares his views about Disney, the most de-risked entertainment company ever, and wonders why, if Trump is so bad for stocks, there's no correction yet.
Investors should keep an eye on interest rates and oil, but remember next week is still a week of big earnings reports, says Jim Cramer.
Teva's rich dividend yield may be too good to continue.
The Dow holds onto gains as oil prices fall and energy shares slide.
Yes, he's unpredictable, but is that a reason to sell?
Stocks lose steam Tuesday as oil prices fall and energy shares slide.
Mylan settled a pay-for-delay lawsuit over its narcolepsy drug, but its share prices are falling.
Jim Cramer discusses why investors should be cautious after Teva Pharmaceutical's CEO left the company.